100g

Bromophenol Blue, Reagent, ACS

Bromophenol Blue, Water Soluble, Reagent, ACS

Bromothymol Blue, Reagent, ACS

Bromothymol Blue, Water Soluble, Reagent, ACS

Brompheniramine Maleate, USP

Brucine Sulfate, Heptahydrate, Reagent, ACS

B- and T-Lymphocyte Attenuator (BTLA) is a single-pass type I membrane protein containing 1 Ig-like V-type (immunoglobulin-like) domain. BTLA expression is induced during activation of T cells, and BTLA remains expressed on Th1 cells but not Th2 cells. Like PD1 and CTLA4, BTLA interacts with a B7 homolog, B7H4. However, unlike PD-1 and CTLA-4, BTLA displays T-Cell inhibition via interaction with tumor necrosis family receptors (TNF-R), not just the B7 family of cell surface receptors. BTLA is a lymphocyte inhibitory receptor that inhibits lymphocytes during immune response. BTLA also is a ligand for tumor necrosis factor (receptor) superfamily, member 14 (TNFRSF14), also known as herpes virus entry mediator (HVEM). BTLAHVEM complexes negatively regulate T-cell immune responses.

Budesonide, Micronized, USP

Bupropion Hydrochloride, USP

Butamben

Butyl Myristate

MUC16, also known as the CA125 antigen, is a mucin protein that may be found in type I transmembrane or secreted forms that are used monitor the progress of epithelial ovarian cancer therapy. Thought to provide a protective, lubricating barrier against particles and infectious agents at mucosal surfaces. Binding to MSLN mediates heterotypic cell adhesion. This may contribute to the metastasis of ovarian cancer to the peritoneum by initiating cell attachment to the mesothelial epithelium via binding to MSLN.

Cacodylic Acid

Caffeic Acid

Calcium Acetate, USP

Calcium Alginate

Calcium Ascorbate, Dihydrate, USP

Calcium Chloride, Desiccant, Reagent, ACS

Calcium D-Pantothenate

Calcium Pantothenate, FCC

Calcium Saccharate, Tetrahydrate, USP

Calcium Silicate, 200 Mesh

Calcium Silicate, NF

Calcium Silicide, -140 Mesh, Powder

Calcium Silicide, Reagent

Calcium Thioglycolate, Trihydrate

Calmagite

Calmagite, Reagent, ACS

Capsaicin, USP

Capsicum Oleoresin

CAPSO Sodium Salt, Biological Buffer

Carbamazepine, USP

Carbidopa, USP

Carbomer 934P, Resin, NF

Carbomer 940, NF

Carbomer 941, NF

Carbon Tetrabromide

Carbon Tetrabromide

Carboxymethylcellulose Calcium Salt

Carmine

Carrageenan, NF

Casein-Hammersten

Castor Oil, Ethoxylated

Catechol

Cathepsin B is an enzymatic protein belonging to the peptidase (or protease) families. The protein encoded by this gene is a lysosomal cysteine protease composed of a dimer of disulfide-linked heavy and light chains, both produced from a single protein precursor. It is a member of the peptidase C1 family. At least five transcript variants encoding the same protein have been found for this gene. Cystatin-B / CSTB is an intracellular thiol proteinase inhibitor. Tightly binding reversible inhibitor of cathepsins L, H and B. Cystatin-B / CSTB is able to form a dimer stabilized by noncovalent forces, inhibiting papain and cathepsins l, h and b. Cystatin-B / CSTB is also thought to play a role in protecting against the proteases leaking from lysosomes.

CCL25 is a new member of the CC family chemokine. It is also called Thymus-expressed chemokine (TECK) because it is restricted produced by thymus and intestine. Especially, the dendritic cells derived from thymus but not bone marrow had been identified to be the source of CCL25. By binding with CCR9, it elicits its effects of chemotactic for thymocytes, macrophages, and dendritic cells. Additionally, CCL25 takes part in regulating the development of T-cells.

B-lymphocyte antigen CD20 or CD20 is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R , CD117 ) and progressively increasing in concentration until maturity.CD20 is the target of the monoclonal antibodies rituximab, ocrelizumab, obinutuzumab, ofatumumab, ibritumomab tiuxetan, tositumomab, and ublituximab, which are all active agents in the treatment of all B cell lymphomas, leukemias, and B cell-mediated autoimmune diseases.

Cell surface glycoprotein CD200 Receptor 1 (CD200R1) is the receptor for the CD200 (OX-2) membrane glycoprotein. CD200R1 contains one C2- type Ig-like domain and one V-type Ig-like domain within its extracellular domain and a PTB-signaling motif in cytoplasmic domain. CD200R1 and CD200 associate via their respective N-terminal Ig-like domains. CD200R1 is restricted primarily to mast cells, basophils, macrophages, and dendritic cells. It propagates inhibitory signals despite its lacking a cytoplasmic ITIM (immunoreceptor tyrosinebased inhibitory motif). The receptor-substrate interaction may function as a myeloid downregulatory signal.